ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 127,80
0,04%
DAX
18 155,24
-0,04%
Brent Oil
84,125
-0,41%
Bitcoin
60 888,46
0,12%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) Actualités

GSK

GSK (GSK)

GSK plc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:GSK
DateHeureSourceTitreSymboleSociété
08/06/202400h57Business WireUS FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased RiskNYSE:GSKGSK plc
03/06/202414h10Business WireJemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancerNYSE:GSKGSK plc
02/06/202416h56Business WireBelantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myelomaNYSE:GSKGSK plc
24/05/202412h24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
21/05/202413h18IH Market NewsCalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils Copilot+ PCs with AI Focus, and More NewsNYSE:GSKGSK plc
17/05/202413h36IH Market NewsOpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More NewsNYSE:GSKGSK plc
07/05/202407h00GlobeNewswire Inc.BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 MillionNYSE:GSKGSK plc
26/04/202413h48IH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNYSE:GSKGSK plc
16/03/202413h00Business WirePositive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancerNYSE:GSKGSK plc
07/03/202418h00Business WireGSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising RiseNYSE:GSKGSK plc
05/03/202418h30Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).NYSE:GSKGSK plc
05/03/202418h10Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NYSE:GSKGSK plc
29/02/202412h11IH Market NewsShares of WW International Plummet after Oprah Exits, EA Announces Workforce Reduction and Restructuring Plan, and Latest NewsNYSE:GSKGSK plc
15/02/202412h34IH Market NewsCisco Systems Stock Drops 5% Following Restructuring Plan, Berkshire Trims Apple Stake, and Latest NewsNYSE:GSKGSK plc
08/02/202413h00GlobeNewswire Inc.Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s DiseaseNYSE:GSKGSK plc
07/02/202422h01GlobeNewswire Inc.23andMe Reports Third Quarter Fiscal 2024 Financial ResultsNYSE:GSKGSK plc
07/02/202413h00GlobeNewswire Inc.FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)NYSE:GSKGSK plc
06/02/202413h00Business WireGSK’s RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased RiskNYSE:GSKGSK plc
31/01/202412h28IH Market NewsWalmart’s Stock Split, Elon Musk’s Billion-Dollar Package Revoked, and MoreNYSE:GSKGSK plc
30/01/202422h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GSKGSK plc
24/01/202420h11Business WireElegen e GSK firmano un accordo di collaborazione e di licenza per sviluppare ulteriormente la tecnologia produttiva del DNA privo di cellule di ElegenNYSE:GSKGSK plc
24/01/202418h52Business WireElegen und GSK unterzeichnen Kooperations- und Lizenzvereinbarung zur Weiterentwicklung der zellfreien DNA-Produktionstechnologie von ElegenNYSE:GSKGSK plc
24/01/202417h37Business WireElegen et GSK signent un accord de collaboration et de licence pour continuer le développement de la technologie de production d’ADN acellulaire d’ElegenNYSE:GSKGSK plc
24/01/202414h00Business WireElegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production TechnologyNYSE:GSKGSK plc
19/01/202422h20Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:GSKGSK plc
18/01/202413h49Dow Jones NewsHilleVax Taps Sean McLoughlin as Chief Operating OfficerNYSE:GSKGSK plc
17/01/202412h33IH Market NewsWall Street Highlights: Tesla Cuts Prices in Germany, Interactive Brokers Increases Revenue by 17%, and MoreNYSE:GSKGSK plc
17/01/202410h04Dow Jones NewsCorrection to GSK Article on TuesdayNYSE:GSKGSK plc
17/01/202408h44Dow Jones NewsGSK Sells Haleon Shares Valued Around $1.24 Billion Through Discounted PlacingNYSE:GSKGSK plc
16/01/202418h19Dow Jones NewsGSK to Sell Haleon Shares Worth Around $1.27 BillionNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Dernières Valeurs Consultées

ASX
CNNN
USOTC
FBPI
First Bancorp of Indiana (PK)
ASX
L1M
Lightning Minerals
NASDAQ
NEBUU
Nebula Acquisition
BIT
P1RRH4
BNP Paribas Issuance
TSXV
SYG.H
Sylla Gold
TG
BATG
Legal & General Ucits Etf
DBI
DL3K
ShortDax X5 AR Total Ret...
ASX
XCLWAY
Australian Commonwealth
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés